U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process (Drugs)
  4. Drug Development Tool Qualification Programs
  5. CDER Biomarker Qualification Program
  1. Development & Approval Process (Drugs)

CDER Biomarker Qualification Program

CDER Biomarker Qualification Program

Biomarker Qualification Program

SPOTLIGHT Events & Announcements

Web content is updated for consistency with 21st Century Cures Act!

Get Started with your submission:

Resources for Biomarker Requestors

MISSION

The mission of the CDER Biomarker Qualification Program (BQP) is to work with external stakeholders to develop biomarkers as drug development tools. Qualified biomarkers have the potential to advance public health by encouraging efficiencies and innovation in drug development. 

About FDA’s Biomarker Qualification Program

 
 

GOALS

  • Support outreach to stakeholders for the identification and development of new biomarkers
  • Provide a framework for the review of biomarkers for use in regulatory decision-making
  • Qualify biomarkers for specific contexts of use that address specified drug development needs

Additional Information

Contact us at: CDER-BiomarkerQualificationProgram@fda.hhs.gov